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The simple fact that this special issue is being published
suggests that “we've come a long way, baby.” From obesity,
vitamin D, and dietary intervention to interventional
cardiology and maternal effects on cardiovascular risk in
offspring, this issue includes more than a conventional
discussion of heart disease in women and differentiates the
dogma from the data. Of course, much remains to be
explored.
Much of the sexual bias in risk, symptom presentation,
and treatment outcome is likely due to pleiotropic effects of
the sex steroids (estrogens, androgens, and progestins) on
cells and tissues involved in the constellation of cardiovas-
cular diseases. From a basic science standpoint, animal
models have taught us much about sex differences in cell
and tissue characteristics, particularly as they contribute to
atherogenic mechanisms. Going forward, in vitro and in
vivo models will be crucial to unraveling the genetics
associated with sex differences. Whereas studies of single
genes can be fruitful, more sophisticated approaches using
microarrays and gene expression profiling such as the
recent study by Mendelsohn and his colleagues [1] have
greater potential for illuminating sex differences in vascular
gene activation and are likely to have significant transla-
tional impact.
From a clinical perspective, the controversy surround-
ing postmenopausal hormone treatment continues as
discussed in the editorials by Barrett-Connor and
Wenger. The suggestion from the Women's Health
Initiative that estrogen intervention at or shortly after the
menopause may be protective [2], now known as the
“critical timing” hypothesis, warrants further investiga-
tion. The Kronos Early Estrogen Prevention Study is
designed to address this very question (see Miller et al. in
this issue). Furthermore, the Women's Ischemia Syndrome
Evaluation Study has shed significant light on the vascular
characteristics underlying the fact that women's symptoms
differ markedly from those of men, a critically important
area of research [3]. In addition, there is much to be done
to improve the pharmacologic treatment of women as
reviewed by Oertelt-Prigone and Regitz-Zagrosek in this
issue. Going forward, we anticipate that the data, the
provocative questions, and the potential for future exper-
imentation presented in this issue will translate into
increased awareness and critical improvements in the
prevention, diagnosis, and treatment of cardiovascular
disease in women.
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